One in Forty Swiss Adults Has Used Ozempic-Style Drugs, and Some Are Sharing Them
A nationally representative Swiss survey finds that 2.5 percent of the population has used GLP-1 receptor agonists, mostly for weight ...
A nationally representative Swiss survey finds that 2.5 percent of the population has used GLP-1 receptor agonists, mostly for weight ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine